Waxman/Hatch Declaratory Judgment Reforms Are Focus Of Zoloft Appeal
This article was originally published in The Pink Sheet Daily
Executive Summary
The Federal Circuit Court of Appeals will hear arguments from Teva and Pfizer Oct. 7 on the impact of Medicare Modernization Act provisions on an ANDA filer’s ability to seek a court order declaring it does not infringe an innovator’s patent.